Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.

Sconocchia G, Eppenberger-Castori S, Zlobec I, Karamitopoulou E, Arriga R, Coppola A, Caratelli S, Spagnoli GC, Lauro D, Lugli A, Han J, Iezzi G, Ferrone C, Ferlosio A, Tornillo L, Droeser R, Rossi P, Attanasio A, Ferrone S, Terracciano L.

Neoplasia. 2014 Jan;16(1):31-42.

2.

Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.

Sakai K, Takiguchi M, Mori S, Kobori O, Morioka Y, Inoko H, Sekiguchi M, Kano K.

J Natl Cancer Inst. 1987 Nov;79(5):923-32.

PMID:
2960847
3.

Differential expression of MHC class II genes in lung tumour cell lines.

Redondo M, Ruiz-Cabello F, Concha A, Hortas ML, Serrano A, Morell M, Garrido F.

Eur J Immunogenet. 1998 Dec;25(6):385-91.

PMID:
9949943
4.

Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma.

Degener T, Momburg F, Möller P.

Virchows Arch A Pathol Anat Histopathol. 1988;412(4):315-22.

PMID:
3125670
5.

Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.

Taramelli D, Fossati G, Mazzocchi A, Delia D, Ferrone S, Parmiani G.

Cancer Res. 1986 Jan;46(1):433-9.

6.

Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues.

Temponi M, Kekish U, Hamby CV, Nielsen H, Marboe CC, Ferrone S.

J Immunol Methods. 1993 May 26;161(2):239-56.

PMID:
8505553
8.

Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.

Jo YS, Lee JC, Li S, Choi YS, Bai YS, Kim YJ, Lee IS, Rha SY, Ro HK, Kim JM, Shong M.

Int J Cancer. 2008 Feb 15;122(4):785-90.

9.

Strong HLA-DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients: Possible involvement of c-myc suppression by interferon-gamma in situ.

Matsushita K, Takenouchi T, Shimada H, Tomonaga T, Hayashi H, Shioya A, Komatsu A, Matsubara H, Ochiai T.

Cancer Sci. 2006 Jan;97(1):57-63.

10.

Induction of major histocompatibility complex class II antigens on human colonic epithelium by interferon-gamma, tumor necrosis factor-alpha, and interleukin-2.

Horie Y, Chiba M, Suzuki T, Kudo T, Kamata A, Iizuka M, Masamune O.

J Gastroenterol. 1998 Feb;33(1):39-47.

PMID:
9497220
11.

Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas.

Dengjel J, Nastke MD, Gouttefangeas C, Gitsioudis G, Schoor O, Altenberend F, Müller M, Krämer B, Missiou A, Sauter M, Hennenlotter J, Wernet D, Stenzl A, Rammensee HG, Klingel K, Stevanović S.

Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4163-70.

12.

Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.

Tsujisaki M, Igarashi M, Sakaguchi K, Eisinger M, Herlyn M, Ferrone S.

J Immunol. 1987 Feb 15;138(4):1310-6.

PMID:
3100635
14.

Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.

Baudeau C, Delarue F, Hé CJ, Nguyen G, Adida C, Peraldi MN, Sraer JD, Rondeau E.

Exp Nephrol. 1994 Sep-Oct;2(5):306-12.

PMID:
7812737
15.

Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness.

Gutierrez J, López-Nevot MA, Cabrera T, Oliva R, Esquivias J, Ruiz-Cabello F, Garrido F.

Exp Clin Immunogenet. 1987;4(3):144-52.

PMID:
2856203
16.

[Expression of HLA-class I and II antigens on basal cell carcinoma].

Nakamura T, Kageshita T, Hirai S, Kimura T, Yoshii A, Ono T, Arao T.

Nihon Hifuka Gakkai Zasshi. 1990 Dec;100(14):1431-5. Japanese.

PMID:
2082044
17.

Altered expression levels of HLA class Ⅱ and costimulatory molecules on circulating monocytes from patients with cervical intraepithelial neoplasia and squamous cervical cancer.

Feng T, Zhou JH, Liu J, Ye F, Lu W, Xie X.

Mol Med Rep. 2012 Dec;6(6):1301-4. doi: 10.3892/mmr.2012.1068. Epub 2012 Sep 10.

PMID:
22965188
20.

Regulation of HLA class II antigen expression on cultured corneal epithelium by interferon-gamma.

Iwata M, Kiritoshi A, Roat MI, Yagihashi A, Thoft RA.

Invest Ophthalmol Vis Sci. 1992 Aug;33(9):2714-21.

PMID:
1639617

Supplemental Content

Support Center